143 related articles for article (PubMed ID: 10541297)
1. Growth hormone receptor antagonism prevents early renal changes in nonobese diabetic mice.
Segev Y; Landau D; Rasch R; Flyvbjerg A; Phillip M
J Am Soc Nephrol; 1999 Nov; 10(11):2374-81. PubMed ID: 10541297
[TBL] [Abstract][Full Text] [Related]
2. A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse.
Landau D; Segev Y; Afargan M; Silbergeld A; Katchko L; Podshyvalov A; Phillip M
Kidney Int; 2001 Aug; 60(2):505-12. PubMed ID: 11473633
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice.
Flyvbjerg A; Bennett WF; Rasch R; Kopchick JJ; Scarlett JA
Diabetes; 1999 Feb; 48(2):377-82. PubMed ID: 10334317
[TBL] [Abstract][Full Text] [Related]
4. Changes in the growth hormone-IGF-I axis in non-obese diabetic mice.
Landau D; Segev Y; Eshet R; Flyvbjerg A; Phillip M
Int J Exp Diabetes Res; 2000; 1(1):9-18. PubMed ID: 11469393
[TBL] [Abstract][Full Text] [Related]
5. Systemic and renal growth hormone-IGF1 axis involvement in a mouse model of type 2 diabetes.
Segev Y; Eshet R; Yakir O; Haim N; Phillip M; Landau D
Diabetologia; 2007 Jun; 50(6):1327-34. PubMed ID: 17443310
[TBL] [Abstract][Full Text] [Related]
6. Compensatory renal growth in uninephrectomized adult mice is growth hormone dependent.
Flyvbjerg A; Bennett WF; Rasch R; van Neck JW; Groffen CA; Kopchick JJ; Scarlett JA
Kidney Int; 1999 Dec; 56(6):2048-54. PubMed ID: 10594780
[TBL] [Abstract][Full Text] [Related]
7. Potential use of growth hormone receptor antagonist in the treatment of diabetic kidney disease.
Flyvbjerg A
Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S115-9. PubMed ID: 11527082
[TBL] [Abstract][Full Text] [Related]
8. Renal hypertrophy in hyperglycemic non-obese diabetic mice is associated with persistent renal accumulation of insulin-like growth factor I.
Segev Y; Landau D; Marbach M; Shehadeh N; Flyvbjerg A; Phillip M
J Am Soc Nephrol; 1997 Mar; 8(3):436-44. PubMed ID: 9071712
[TBL] [Abstract][Full Text] [Related]
9. The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease.
Kucukhuseyin O; Toptas B; Timirci-Kahraman O; Isbir S; Karsidag K; Isbir T
In Vivo; 2015; 29(3):371-8. PubMed ID: 25977383
[TBL] [Abstract][Full Text] [Related]
10. The effect of growth hormone on the development of diabetic kidney disease in rats.
Landau D; Israel E; Rivkis I; Kachko L; Schrijvers BF; Flyvbjerg A; Phillip M; Segev Y
Nephrol Dial Transplant; 2003 Apr; 18(4):694-702. PubMed ID: 12637637
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice.
Grønbaek H; Nielsen B; Schrijvers B; Vogel I; Rasch R; Flyvbjerg A
J Endocrinol; 2002 Mar; 172(3):637-43. PubMed ID: 11874712
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
[TBL] [Abstract][Full Text] [Related]
13. The role of growth hormone in the pathogenesis of diabetic kidney disease.
Flyvbjerg A
Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():525-9. PubMed ID: 16444187
[TBL] [Abstract][Full Text] [Related]
14. Comparison between somatostatin analogues and ACE inhibitor in the NOD mouse model of diabetic kidney disease.
Segev Y; Eshet R; Rivkis I; Hayat C; Kachko L; Phillip M; Landau D
Nephrol Dial Transplant; 2004 Dec; 19(12):3021-8. PubMed ID: 15494355
[TBL] [Abstract][Full Text] [Related]
15. Effect of dietary energy and somatotropin on components of the somatotropic axis in Holstein heifers.
Radcliff RP; VandeHaar MJ; Kobayashi Y; Sharma BK; Tucker HA; Lucy MC
J Dairy Sci; 2004 May; 87(5):1229-35. PubMed ID: 15290971
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific regulation of the growth hormone receptor gene in streptozocin-induced diabetes in the rat.
Menon RK; Stephan DA; Rao RH; Shen-Orr Z; Downs LS; Roberts CT; LeRoith D; Sperling MA
J Endocrinol; 1994 Sep; 142(3):453-62. PubMed ID: 7964296
[TBL] [Abstract][Full Text] [Related]
17. Renal growth hormone receptor gene expression: relationship to renal insulin-like growth factor system.
Chin E; Zhou J; Bondy CA
Endocrinology; 1992 Dec; 131(6):3061-6. PubMed ID: 1446640
[TBL] [Abstract][Full Text] [Related]
18. Dose-response effects of a new growth hormone receptor antagonist (B2036-PEG) on circulating, hepatic and renal expression of the growth hormone/insulin-like growth factor system in adult mice.
van Neck JW; Dits NF; Cingel V; Hoppenbrouwers IA; Drop SL; Flyvbjerg A
J Endocrinol; 2000 Nov; 167(2):295-303. PubMed ID: 11054644
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist.
Iida K; Del Rincon JP; Kim DS; Itoh E; Nass R; Coschigano KT; Kopchick JJ; Thorner MO
Endocrinology; 2004 Apr; 145(4):1564-70. PubMed ID: 14726438
[TBL] [Abstract][Full Text] [Related]
20. The response of the hepatic insulin-like growth factor system to growth hormone and dexamethasone in calves.
Hammon HM; Zbinden Y; Sauerwein H; Breier BH; Blum JW; Donkin SS
J Endocrinol; 2003 Dec; 179(3):427-35. PubMed ID: 14656212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
